The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
Clarivate Plc (NYSE: CLVT) closed the day trading at $4.05 down -4.26% from the previous closing price of $4.23. In other words, the price has decreased by -$4.26 from its previous closing price. On the day, 7.17 million shares were traded. CLVT stock price reached its highest trading level at $4.77 during the session, while it also had its lowest trading level at $3.965.
Ratios:
For a better understanding of CLVT, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.63 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.49. For the most recent quarter (mrq), Quick Ratio is recorded 0.91 and its Current Ratio is at 0.91. In the meantime, Its Debt-to-Equity ratio is 0.92 whereas as Long-Term Debt/Eq ratio is at 0.91.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on July 18, 2025, initiated with a Hold rating and assigned the stock a target price of $4.50.
On July 18, 2025, Jefferies Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $4.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 01 ’25 when Samson James Gordon sold 100,000 shares for $4.53 per share. The transaction valued at 453,000 led to the insider holds 1,271,103 shares of the business.
Snyder Andrew Miles bought 237,176 shares of CLVT for $989,024 on Mar 14 ’25. The Director now owns 787,510 shares after completing the transaction at $4.17 per share. On Mar 12 ’25, another insider, Bomba Jane L Okun, who serves as the Director of the company, bought 49,750 shares for $4.03 each. As a result, the insider paid 200,492 and bolstered with 49,750 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLVT now has a Market Capitalization of 2766502400 and an Enterprise Value of 6946587136. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.11 while its Price-to-Book (P/B) ratio in mrq is 0.55. Its current Enterprise Value per Revenue stands at 2.778 whereas that against EBITDA is 7.585.
Stock Price History:
The Beta on a monthly basis for CLVT is 1.41, which has changed by -0.375 over the last 52 weeks, in comparison to a change of 0.16821623 over the same period for the S&P500. Over the past 52 weeks, CLVT has reached a high of $7.15, while it has fallen to a 52-week low of $3.04. The 50-Day Moving Average of the stock is -5.67%, while the 200-Day Moving Average is calculated to be -14.49%.
Shares Statistics:
Over the past 3-months, CLVT traded about 5.28M shares per day on average, while over the past 10 days, CLVT traded about 4445350 shares per day. A total of 672.20M shares are outstanding, with a floating share count of 387.35M. Insiders hold about 43.29% of the company’s shares, while institutions hold 63.91% stake in the company. Shares short for CLVT as of 1752537600 were 38797868 with a Short Ratio of 7.35, compared to 1749772800 on 36902193. Therefore, it implies a Short% of Shares Outstanding of 38797868 and a Short% of Float of 8.59.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
